FDA Warns Not to Rely on Pulse Oximetry for Diagnosis, Treatment Decisions
Safety communication follows NEJM study showing risk for inaccuracy with use of pulse oximeters in those with dark skin pigmentation
COVID-19 Vaccines Adapted to Fight Variants Will Not Require Long Clinical Trials: FDA
Most makers of approved COVID-19 vaccines have said they plan to adapt their vaccines to tackle variants
Vascular Deaths Down for Diabetes Patients in the U.K.
Cancer is now the leading contributor to death among individuals with diabetes living in England
Amoxicillin-Clavulanate Effective for Outpatients With Diverticulitis
As effective as metronidazole with fluoroquinolone, with reduced risk for one-year Clostridioides difficile infection
FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking
Agency offers recommendations for companies seeking to modify already-approved vaccines, medicines, and tests so they can remain effective
Risk for Rheumatoid Arthritis Reduced for Patients With T2DM
Reduced risk may be attributable to statin use; no significant association seen for glycemic control, metformin use on RA risk
Children Conceived by ART Are Shorter, Lighter at Birth
Children conceived by assisted reproduction technology grow more rapidly after birth; height, weight similar to those naturally conceived by 17
CDC Report Shows No Evidence of Unexpected Adverse Events With COVID-19 Vaccines
Findings from the first month show no unexpected adverse events, with 6,994 adverse events and >90 percent classified as nonserious
SARS-CoV-2, COVID-19 Rates Decreased After One Vaccine Dose
Study among health care workers shows reductions in SARS-CoV-2 infection rates one to 14, 15 to 28 days after first dose of the BNT162b2 COVID-19 vaccine
Persistent Symptoms Reported for About 30 Percent With COVID-19
At least one persistent symptom reported by 32.7 percent of outpatients with mild illness, 31.3 percent of patients hospitalized
